The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Carbonic Anhydrase IX Expression, a Novel Surrogate Marker of Tumor Hypoxia, Is Associated With a Poor Prognosis in Non–Small-Cell Lung Cancer
Abstract
Purpose: To evaluate carbonic anhydrase (CA) IX as a surrogate marker of hypoxia and investigate the prognostic significance of different patterns of expression in non–small-cell lung cancer (NSCLC). Methods: Standard immunohistochemical techniques were used to study CA IX expression in 175 resected NSCLC tumors. CA IX expression was determined by Western blotting in A549 cell lines grown under normoxic and hypoxic conditions. Measurements from microvessels to CA IX positivity were obtained. Results: CA IX immunostaining was detected in 81.8% of patients. Membranous (m) (P = .005), cytoplasmic (c) (P = .018), and stromal (P < .001) CA IX expression correlated with the extent of tumor necrosis (TN). The mean distance from vascular endothelium to the start of tumor cell positivity was 90 μm, which equates to an oxygen pressure of 5.77 mmHg. The distance to blood vessels from individual tumor cells or tumor cell clusters was greater if they expressed mCA IX than if they did not (P < .001). Hypoxic exposure of A549 cells for 16 hours enhanced CA IX expression in the nuclear and cytosolic extracts. Perinuclear (p) CA IX (P = .035) was associated with a poor prognosis. In multivariate analysis, pCA IX (P = .004), stage (P = .001), platelet count (P = .011), sex (P = .027), and TN (P = .035) were independent poor prognostic factors. Conclusion: These results add weight to the contention that mCA IX is a marker of tumor cell hypoxia. The absence of CA IX staining close to microvessels suggests that these vessels are functionally active. pCA IX expression is representative of an aggressive phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy
Thomlinson, R. H., & Gray, L. H. (1955) · British Journal of Cancer · doi:10.1038/bjc.1955.55 · Cited by 2,219
Giatromanolaki, A., Koukourakis, M. I., Sivridis, E., Turley, H., Talks, K., Pezzella, F., Gatter, K. C., & Harris, A. L. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2018 · Cited by 478
Self-citationChia, S. K., Wykoff, C. C., Watson, P. H., Han, C., Leek, R. D., Pastorek, J., Gatter, K. C., Ratcliffe, P., & Harris, A. L. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.16.3660 · Cited by 432
Self-citationVaria, M. A., Calkins-Adams, D. P., Rinker, L. H., Kennedy, A. S., Novotny, D. B., Fowler, W. C., & Raleigh, J. A. (1998) · Gynecologic Oncology · doi:10.1006/gyno.1998.5163 · Cited by 342
Raleigh, J. A., Chou, S.-C., Arteel, G. E., & Horsman, M. R. (1999) · Radiation Research · doi:10.2307/3580034 · Cited by 304
A novel quasi-viral agent, MaTu, is a two-component system
Pastoreková, S., Závadová, Z., Košťál, M., Babušíková, O., & Závada, J. (1992) · Virology · doi:10.1016/0042-6822(92)90464-z · Cited by 287
Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro
Parkkila, S., Rajaniemi, H., Parkkila, A.-K., Kivelä, J., Waheed, A., Pastoreková, S., Pastorek, J., & Sly, W. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040554897 · Cited by 278
Self-citationCarbonic anhydrase inhibitors: Sulfonamides as antitumor agents?
Supuran, C. T., Briganti, F., Tilli, S., Chegwidden, W. R., & Scozzafava, A. (2001) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(00)00288-1 · Cited by 277
O'Byrne, K. J., Koukourakis, M. I., Giatromanolaki, A., Cox, G., Turley, H., Steward, W. P., Gatter, K., & Langrish, V (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1129 · Cited by 275
Self-citationSaarnio, J., Parkkila, S., Parkkila, A.-K., Haukipuro, K., Pastoreková, S., Pastorek, J., Kairaluoma, M. I., & Karttunen, T. J. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65569-1 · Cited by 270
Self-citationInfluence of the hypoxic subvolume on the survival of patients with head and neck cancer
Stadler, P., Becker, A., Jürgen Feldmann, H., Hänsgen, G., Dunst, J., Würschmidt, F., & Molls, M. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00115-7 · Cited by 266
Wykoff, C. C., Beasley, N., Watson, P. H., Campo, L., Chia, S. K., English, R., Pastorek, J., Sly, W. S., Ratcliffe, P., & Harris, A. L. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64048-5 · Cited by 249
Self-citationExpression of MaTu‐MN protein in human tumor cultures and in clinical specimens
Závada, J., Závadová, Z., Pastoreková, S., Čiampor, F., Pastorek, J., & Zelník, V. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910540218 · Cited by 204
Self-citationSwinson, D. E. B., Jones, J. L., Richardson, D., Cox, G., Edwards, J. G., & O'Byrne, K. J. (2002) · Lung Cancer · doi:10.1016/s0169-5002(02)00172-1 · Cited by 183
Self-citationPredictive factors in radiotherapy for non-small cell lung cancer: present status
Choi, N. C., Baumann, M. A., Flentjie, M., Kellokumpu‐Lehtinen, P., Senan, S., Zamboglou, N., & Kosmidis, P. (2001) · Lung Cancer · doi:10.1016/s0169-5002(00)00156-2 · Cited by 92
Clarke, K., Smith, K. J., Gullick, W., & Harris, A. L. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1805 · Cited by 89
Self-citationVascular injury in transplanted tissues
Ausprunk, D. H., & Folkman, J. (1976) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02899142 · Cited by 41
Nuclear NonO/p54nrb Protein Is a Nonclassical Carbonic Anhydrase
Karhumaa, P., Parkkila, S., Waheed, A., Parkkila, A., Kaunisto, K., Tucker, P. W., Huang, C.-J., Sly, W. S., & Rajaniemi, H. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.21.16044 · Cited by 33
Cited by
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
Supuran, C. T. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2467 · Cited by 3,192
Hypoxic gene expression and metastasis
Le, Q.-T., Denko, N. C., & Giaccia, A. J. (2004) · Cancer and Metastasis Reviews · doi:10.1023/b:canc.0000031768.89246.d7 · Cited by 468
Recent Developments in Targeting Carbonic Anhydrase IX for Cancer Therapeutics
McDonald, P. C., Winum, J.-Y., Supuran, C. T., & Dedhar, S. (2012) · Oncotarget · doi:10.18632/oncotarget.422 · Cited by 421
Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers
Winter, S. C., Buffa, F. M., Silva, P., Miller, C., Valentine, H. R., Turley, H., Shah, K. A., Cox, G. J., Corbridge, R. J., Homer, J. J., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3322 · Cited by 410
“Although high expression of HIF-1a and CA9 was thought to reflect the hypoxic nature of a tumor and activation of the HIF pathway, other studies reported no association with survival (31, 32) or association for only one factor (33).”
BackgroundSelf-citationUnderstanding the tumor microenvironment for effective immunotherapy
Sadeghi Rad, H., Monkman, J., Warkiani, M. E., Ladwa, R., O'Byrne, K., Rezaei, N., & Kulasinghe, A. (2021) · Medicinal Research Reviews · doi:10.1002/med.21765 · Cited by 334
Self-citation
Metadata
- Authors
- Swinson, D. E. B., Jones, J. L., Richardson, D., Wykoff, C., Turley, H., Pastorek, J., Taub, N., Harris, A. L., & O’Byrne, K. J.
- Venue
- Journal of Clinical Oncology
- Published
- 2003-02-01
- Volume
- 21
- Issue
- 3
- Pages
- 473-482
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1523383495
- Cited by
- 287
- References
- 18
- FWCI
- 5.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.